NOLCX
Price
$34.78
Change
-$0.26 (-0.74%)
Updated
Jul 13 closing price
Net Assets
366.21M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

NOLCX vs VSTSX

NOLCX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
NOLCX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NOLCX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. NOLCX (366M). VSTSX pays higher dividends than NOLCX: VSTSX (1.07) vs NOLCX (0.82). NOLCX was incepted earlier than VSTSX: NOLCX (21 years) vs VSTSX (10 years). NOLCX (0.55) is less costly to investors than VSTSX (0.01). NOLCX is a more actively managed with annual turnover of: 43.13 vs. VSTSX (3.00). NOLCX has a lower initial minimum investment than VSTSX: NOLCX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. NOLCX (15.41). VSTSX return over 5 years is better than : 66.56 vs. NOLCX (33.87).
NOLCXVSTSXNOLCX / VSTSX
Total Expense Ratio0.450.014,500%
Annual Report Gross Expense Ratio0.550.015,500%
Fund Existence21 years10 years-
Gain YTD10.85211.20597%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets366M2.3T0%
Annual Yield % from dividends0.821.0776%
Returns for 1 year15.4121.4872%
Returns for 3 years45.6767.0668%
Returns for 5 years33.8766.5651%
Returns for 10 years158.33239.5366%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I